Finland vs Norway: Cause of death, by non-communicable diseases, ages 5-14, male
Finland
71.6%
in 2021
Norway
69.1%
in 2021
Finland rank
10th
Norway rank
13th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Finland
- Norway
How they compare
Finland currently reports 71.6% against 69.1% in Norway, a difference of 2.5%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Norway ahead.
Finland ranks 10th and Norway ranks 13th of 185 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Finland | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.7% | 47.4% | 2.7% | Norway |
| 2010s | 53.7% | 65.0% | 11.3% | Norway |
| 2020s | 65.3% | 67.1% | 1.8% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Finland or Norway?
- Finland, at 71.6% against 69.1% in Norway as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Finland and Norway?
- 2.5%, with Finland ahead.
- How many years of comparable data are there for Finland and Norway?
- 6 years are reported by both, from 2000 to 2021.
- How do Finland and Norway rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Finland ranks 10th and Norway ranks 13th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.